GSK3B and cancer: Therefore, combination of TRAIL and chemotherapeutic drugs may be a good strategy for treatment of cancer with multidrug resistance, and DNA-PKcs/Akt/GSK-3β signaling pathway may be an important target to overcome multidrug resistance.